Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Pharmacology & Therapeutics|October 13, 2017
Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infectionUlrich Spengler
Journal of Hepatology|January 23, 2009
Hepatic microcirculation: a critical but neglected factor for the outcome of viral hepatitisUlrich Spengler
Therapeutische Umschau. Revue Therapeutique|June 1, 2010
[Non adherence - non response in transplantation medicine]Ulrich Spengler
Current Opinion in HIV and AIDS|September 16, 2011
Management of end-stage liver disease in HIV/hepatitis C virus co-infectionUlrich Spengler
Clinical Science (London, England : 1979)|January 4, 2007
Immunopathogenesis in hepatitis C virus cirrhosisUlrich Spengler, Jacob Nattermann
Clinical Reviews in Allergy & Immunology|July 16, 2008
Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?Birgit Terjung, Ulrich Spengler
Clinical Reviews in Allergy & Immunology|May 10, 2005
Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseasesBirgit Terjung, Ulrich Spengler
The Lancet. Infectious Diseases|June 29, 2004
HIV and hepatitis C virus co-infectionJürgen Kurt Rockstroh, Ulrich Spengler
Current Molecular Pharmacology|December 22, 2009
Host genetic factors and treatment of hepatitis CJacob Nattermann, Ludger Leifeld, Ulrich Spengler
Deutsches Arzteblatt International|March 19, 2013
The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosisTilman Sauerbruch, Beate Appenrodt, Volker Schmitz, et al.
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Pharmacology & Therapeutics|October 13, 2017
Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infectionUlrich Spengler
Journal of Hepatology|January 23, 2009
Hepatic microcirculation: a critical but neglected factor for the outcome of viral hepatitisUlrich Spengler
Therapeutische Umschau. Revue Therapeutique|June 1, 2010
[Non adherence - non response in transplantation medicine]Ulrich Spengler
Current Opinion in HIV and AIDS|September 16, 2011
Management of end-stage liver disease in HIV/hepatitis C virus co-infectionUlrich Spengler
Clinical Science (London, England : 1979)|January 4, 2007
Immunopathogenesis in hepatitis C virus cirrhosisUlrich Spengler, Jacob Nattermann
Clinical Reviews in Allergy & Immunology|July 16, 2008
Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?Birgit Terjung, Ulrich Spengler
Clinical Reviews in Allergy & Immunology|May 10, 2005
Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseasesBirgit Terjung, Ulrich Spengler
The Lancet. Infectious Diseases|June 29, 2004
HIV and hepatitis C virus co-infectionJürgen Kurt Rockstroh, Ulrich Spengler
Current Molecular Pharmacology|December 22, 2009
Host genetic factors and treatment of hepatitis CJacob Nattermann, Ludger Leifeld, Ulrich Spengler
Deutsches Arzteblatt International|March 19, 2013
The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosisTilman Sauerbruch, Beate Appenrodt, Volker Schmitz, et al.
Pageof 23